Fernández VMU, Calderón LCF

Language: Spanish
References: 13
Page: 307-311
PDF size: 215.92 Kb.

ABSTRACT

Introduction: during December 2019, a new coronavirus, named SARS-CoV-2, by the International Committee on Taxonomy of Viruses, was identified in Wuhan, China. After presenting with this disease, sequelae such as anxiety and depression have been found. Objective: determine the level of anxiety and depression in post-COVID-19 patients of the Family Medicine Unit No. 34. Material and methods: observational, descriptive, cross-sectional, unicentric, homodemic, prospective, prolective study. It was conducted in a first level unit of the Mexican Institute of Social Security, in the period from January 2021 to January 2022. The Hamilton Anxiety Scale and the Beck Depression Inventory were applied. Statistical analysis was performed in the SPSS 25 program, data were expressed as mean ± standard deviation or median, according to the distribution. Qualitative variables were expressed as frequencies and percentages. Results: the mean age was 27 years; with a predominance of females (62.4%), 6% presented moderate depression, 1.5% severe depression, 20.9% mild anxiety and 9.8% moderate or severe anxiety. Conclusions: there is an association between the level of depression and anxiety in post-COVID-19 patients, with a significant p.

REFERENCES

1. Palacios M, Santos E, Velázquez M, León M. COVID-19, una emergencia de salud pública mundial. Rev Clin Esp. 2020; 1 (221): 55-61.

2. Organización Panamericana de la Salud / Organización Mundial de la Salud. Actualización Epidemiológica Enfermedad por coronavirus (COVID-19). 11 de diciembre de 2020.

3. Escudero X, Guarner J, Galindo A, Escudero M, Alcocer M, Del Rio C. La pandemia de coronavirus SARS-CoV-2 (COVID-19): situación actual e implicaciones para México. Cardiovasc Metab Sci 2020; 31 (3): 170-177.

4. Matalon N, Dorman S, Hasson I, Hertz N, Shani S, Basel D et al. Trajectories of post-traumatic stress symptoms, anxiety, and depression in hospitalized COVID-19 patients: a one-month follow-up. J Psychosom Res. 2021; 143: 110399.

5. Mazza M, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020; 89: 594-600.

6. Kong X, Zheng K, Tang M, Kong F, Zhou J, Diao L et al. Prevalence and factors associated with depression and anxiety of hospitalized patients with COVID-19. 2020; (8) 42.

7. Secretaría de Salud. Guía de práctica clínica Diagnóstico y tratamiento de los trastornos de ansiedad den el adulto. 2020.

8. Organización Mundial de la Salud. Depresión. 13 septiembre 2021.

9. Maslakci A, Sürücü L. Gender Effects on Depression, Anxiety, and Stress Regarding the Fear of COVID-19. Trends in Psychol. 2022; 1-13.

10. Almeida M, Shrestha A, Stojanac D, Miller L. The impact of the COVID-19 pandemic on women's mental helth. Arch Womens Mental Health 2020; 23: 741-748.

11. Ayuso B, Pérez A, Besteiro Y, Romay E, Garcia M, Marchán Á et al. Calidad de vida relacionada con la salud en pacientes recuperados de COVID-19. [Health-related quality of life in patients recovered from COVID-19]. J Healthc Qual Res. 2022; 37 (4): 208-215.

12. Universidad de Alcalá, ¿Hay relación entre el nivel educativo y la depresión?: Disponible en: https://portalcomunicacion.uah.es/diario-digital/actualidad/hay-relacion-entre-el-nivel-educativo-y-la-depresion.html

13. Parker C, Shalev D, Hsu I, Shenoy A, Cheung S, Nash S et al. Depression, anxiety and acute stress disorder among patients hospitalized with COVID-19: a prospective cohort study. J Acad Consul Liaison Psychiatry. 2021; 62 (2): 211-219.